Michelle Schaffer
9Patents
3h-index
9Co-inventors
46Inventor score
Filing activity: Feb 1, 2002 → Dec 14, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7432244B2 | Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides | Chemistry; Metallurgy | 8 | Active |
| US7071300B2 | IGF antagonist peptides | Chemistry; Metallurgy | 8 | Expired |
| US7084240B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 4 | Expired |
| US7238658B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 1 | Expired |
| US9458102B2 | Derivatives of tetracaine | Chemistry; Metallurgy | 0 | Active |
| US7596455B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
| US7433788B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
| US7297763B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
| US7354769B2 | Crystallization of IGF-1 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.